By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Bile acid sequestrants > Colestipol > Colestipol Dosage
Bile acid sequestrants
https://themeditary.com/dosage-information/colestipol-dosage-9037.html

Colestipol Dosage

Drug Detail:Colestipol (Colestipol [ koe-les-ti-pol ])

Drug Class: Bile acid sequestrants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hyperlipoproteinemia

Tablets:

  • Initial dose: 2 g orally once or twice a day
  • Maintenance dose: 2 to 16 g once a day or in divided doses

Comments:
  • Dose increases of 2 g once or twice a day should occur at 1 to 2 month intervals.
  • If desired therapeutic effect on low density lipoprotein (LDL) cholesterol is not obtained at a dose of 2 to 16 g per day with good compliance and acceptable side effects, combined therapy or alternate treatment should be considered.

Granules:
  • Initial dose: 5 g (1 packet or 1 level scoop) orally once or twice a day
  • Maintenance dose: 5 to 30 g (1 to 6 packets or level scoops) orally once a day or in divided doses

Comments:
  • Incremental dose increases should occur at a rate of 1 dose per day at 1 to 2 month intervals.
  • If desired therapeutic effect is not obtained at 1 to 6 doses per day with good compliance and acceptable side effects, combined therapy or alternate treatment should be considered.

Use: For use as adjunctive treatment to diet for the reduction of elevated serum total and low-density lipoprotein (LDL) cholesterol in patients with primary hypercholesterolemia (elevated LDL) who do not respond adequately to diet

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Patients with preexisting constipation:

  • Tablets: Initiate with 2 g orally once or twice a day; if the initial dose is well tolerated, the dose may be increased as needed by a further 2 to 4 g per day at monthly intervals with periodic monitoring of serum lipoproteins.
  • Granules: Initiate with 5 g (1 packet or 1 level scoop) orally once a day for 5 to 7 days; increasing to twice a day with monitoring of constipation and of serum lipoproteins, at least twice, 4 to 6 weeks apart; if the initial dose is well tolerated, the dose may be increased as needed by one dose/day (at monthly intervals) with periodic monitoring of serum lipoproteins.

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Tablets: Swallow tablets one at a time with plenty of water or other appropriate liquid; swallow whole and do not cut, crush, or chew tablets.
  • Granules: Do not take in dry form; always mix with water or other fluids prior to ingestion.
  • Other medications should be taken at least 1 hour before or 4 hours after colestipol to avoid impeding their absorption.

Reconstitution/preparation techniques:
  • Mix the prescribed amount with 3 ounces or more with water or other beverage, including a heavy or pulpy juice, and stir to uniform consistency and drink.
  • May be taken mixed with milk in hot or regular breakfast cereals or soups that have a high fluid content; may also be added to fruits that are pulpy such as crushed pineapple, pears, peaches, or fruit cocktail.
  • May also be mixed with carbonated beverages, however, this may be associated with gastrointestinal complaints.
  • Rinse glass with a small amount of additional beverage to be sure all medication is taken.

General:
  • Prior to initiating therapy, define the type of hyperlipoproteinemia, institute a trial of diet and weight reduction, and establish baseline serum total cholesterol, LDL cholesterol, and triglyceride levels.
  • A significant rise in triglyceride levels should be considered as indication for dose reduction, drug discontinuation, or combined or alternate therapy.

Monitoring:
  • Metabolic: Baseline serum total cholesterol, LDL cholesterol, and triglyceride levels should be obtained and then periodically measured during therapy.

Patient advice:
  • Difficulty swallowing and obstruction of the esophagus has rarely been reported; however, if a tablet gets stuck after you swallow it, you may notice pressure or discomfort. If this happens to you, do not take another dose and contact your doctor.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by